Akums Drugs IPO Reservation
The Akums Drugs IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 2,73,68,151 equity shares are available for allocation across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Employees.
The Retail Individual Investor (RII) category has the highest allocation with 27,12,424 shares, representing 9.91% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 81,37,276 shares (29.73%), while Non-Institutional Investors (NIIs) receive 40,68,637 shares (14.87%). The NII portion is further divided into Big Non-Institutional Investors (BNII) with 27,12,425 shares (9.91%) and Small Non-Institutional Investors (SNII) with 13,56,212 shares (4.96%).
The IPO also includes a dedicated reservation for Employees, comprising 2,43,902 shares (0.89%). This category-wise reservation provides a clear view of how the IPO shares are distributed among eligible investor groups.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Anchor Investors | 12205912 | 44.6 | 0 |
| Qualified Institutions | 8137276 | 29.73 | 0 |
| Non-Institutional | 4068637 | 14.87 | 0 |
| BNII | 2712425 | 9.91 | 8806 |
| SNII | 1356212 | 4.96 | 4403 |
| Retail Investors | 2712424 | 9.91 | 123292 |
| Employees | 243902 | 0.89 | 0 |
| Total | 27368151 | 100 | 0 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the retail investor quota in the Akums Drugs IPO?
The Retail Individual Investor (RII) quota in the Akums Drugs IPO comprises 27,12,424 equity shares, representing 9.91% of the total IPO issue.
What is the reservation for QIBs in the Akums Drugs IPO?
Qualified Institutional Buyers (QIBs) have been allocated 81,37,276 equity shares, representing 29.73% of the total IPO issue.
What is the reservation for HNI investors in the Akums Drugs IPO?
The Non-Institutional Investors (NII) category has been allotted 40,68,637 equity shares (14.87%). This category is further divided into: Big HNI (bNII): 13,56,212 shares (9.91%) Small HNI (sNII): 27,12,425 shares (4.96%).
What is the category-wise reservation in the Akums Drugs IPO?
The Akums Drugs IPO reservation is divided as follows: Qualified Institutional Buyers (QIB): 81,37,276 shares (29.73%). Non-Institutional Investors (NII): 40,68,637 shares (14.87%). Retail Individual Investors (RII): 27,12,424 shares (9.91%). Employees: 2,43,902 shares (0.89%).
Is there an employee reservation in the Akums Drugs IPO?
Yes. The Akums Drugs IPO has reserved 2,43,902 equity shares, representing 0.89% of the total issue for eligible employees.
Is there a shareholder quota in the Akums Drugs IPO?
No. The Akums Drugs IPO does not include a shareholder reservation.